Studies in cultured cells have confirmed that S6K activity is enhanced by mechanisms activating the PI3-kinase/Akt/mTOR pathway, such as loss of the tumour suppressor PTEN, and have shown a positive correlation between S6K activity and tumour growth [13]. The gene discussed is MTOR; the disease is neoplasm.